Amedeo Smart

Free Medical Literature Service

 

Amedeo

Schizophrenia
  Free Subscription

Articles published in
Am J Psychiatry
    December 2025
  1. KELLNER CH
    Electroconvulsive Therapy (ECT) for Postpartum Psychosis: Treatment for a Medical Emergency.
    Am J Psychiatry. 2025;182:1093.
    >> Share

  2. BERGINK V, Kamperman A, Robakis T
    Electroconvulsive Therapy (ECT) for Postpartum Psychosis: Treatment for a Medical Emergency: Response to Kellner.
    Am J Psychiatry. 2025;182:1094.
    >> Share

    November 2025
  3. KANTROWITZ JT, Mayer MR, Choo TH, Liu K, et al
    Effect Size Deflation With Increasing Sample Size in Adjunctive Trials for Negative Symptoms in Schizophrenia: A Meta-Analysis and Meta-Regression Across Mechanisms of Action.
    Am J Psychiatry. 2025 Nov 19:appiajp20250034. doi: 10.1176/appi.ajp.20250034.
    >> Share

  4. LANG U, Metsala J, Ramsay H, Boland F, et al
    Doxycycline Use in Adolescent Psychiatric Patients and Risk of Schizophrenia: An Emulated Target Trial.
    Am J Psychiatry. 2025 Nov 5:appiajp20240958. doi: 10.1176/appi.ajp.20240958.
    >> Share

  5. KALIN NH
    Schizophrenia, Alcohol Use Disorder, and Stimulant Use Disorder.
    Am J Psychiatry. 2025;182:957-959.
    >> Share

  6. YALCINBAS EA, Ajanaku B, Nelson ED, Garcia-Flores R, et al
    Transcriptomic Analysis of the Human Habenula in Schizophrenia.
    Am J Psychiatry. 2025;182:991-1006.
    >> Share

  7. GUR RE
    Pathways to Psychosis: Factors Associated With Risk for Psychosis Spectrum Disorders.
    Am J Psychiatry. 2025;182:984-990.
    >> Share

    October 2025
  8. ZHAO G, Sun Y, Zhang Y, Lu T, et al
    Efficacy and Tolerability of Seven Antipsychotic Drugs in Acutely Ill Patients With Schizophrenia: A Randomized, Multicenter, Assessor-Blinded Trial.
    Am J Psychiatry. 2025 Oct 29:appiajp20250111. doi: 10.1176/appi.ajp.20250111.
    >> Share

  9. HOWES OD, Bukala BR, Chen EYH, Correll CU, et al
    Relapse in Schizophrenia: A Systematic Review of Criteria for Clinical Studies and International Consensus Guidelines to Improve Them.
    Am J Psychiatry. 2025 Oct 8:appiajp20241040. doi: 10.1176/appi.ajp.20241040.
    >> Share

    September 2025
  10. KALIN NH
    Scientific Advances Relevant to Schizophrenia, Psychosis, and the Treatment of Methamphetamine Use Disorder.
    Am J Psychiatry. 2025;182:797-800.
    >> Share

  11. HORAN WP, Harvey PD, Brannan SK
    Does Xanomeline/Trospium Have Unique Benefits for Cognitive Impairment Associated With Schizophrenia? Response to Tandon.
    Am J Psychiatry. 2025;182:878-879.
    >> Share

  12. CASSIDY C, Wang Y, Abi-Dargham A
    Forging a Role for Iron in the Dopamine Dysfunction of Schizophrenia.
    Am J Psychiatry. 2025;182:804-806.
    >> Share

  13. VANO LJ, McCutcheon RA, Sedlacik J, Kaar SJ, et al
    Reduced Brain Iron and Striatal Hyperdopaminergia in Schizophrenia: A Quantitative Susceptibility Mapping MRI and PET Study.
    Am J Psychiatry. 2025;182:830-839.
    >> Share

  14. TANDON R
    Does Xanomeline/Trospium Have Unique Benefits for Cognitive Impairment Associated With Schizophrenia?
    Am J Psychiatry. 2025;182:878.
    >> Share

  15. ANGLIN DM, Olfson M, van der Ven E, Oh H, et al
    Neighborhood Social Vulnerability and Racial Disparities in Schizophrenia Spectrum Disorder Prevalence.
    Am J Psychiatry. 2025;182:850-860.
    >> Share

    July 2025
  16. AHN Y, Kim J, Jung K, Lee DJ, et al
    Relationship Between Problematic Alcohol Use and Various Psychiatric Disorders: A Genetically Informed Study.
    Am J Psychiatry. 2025;182:671-682.
    >> Share

    June 2025
  17. WARD HB, Beermann A, Manzanarez Felix K, Narisetti L, et al
    Grip Strength as a Marker of Resting-State Network Integrity and Well-Being in Early Psychosis.
    Am J Psychiatry. 2025 Jun 25:appiajp20240780. doi: 10.1176/appi.ajp.20240780.
    >> Share

  18. KALIN NH
    Depression, Inflammation, and Postpartum Psychosis.
    Am J Psychiatry. 2025;182:501-503.
    >> Share

  19. DAZZAN P
    A Step Closer to Understanding Familial Risk for Postpartum Psychosis.
    Am J Psychiatry. 2025;182:504-505.
    >> Share

    May 2025
  20. ZHANG L, Ivleva EI, Parker DA, Hill SK, et al
    Impact of Polygenic Interactions With Anticholinergic Burden on Cognition and Brain Structure in Psychosis Spectrum Disorders.
    Am J Psychiatry. 2025 May 28:appiajp20240709. doi: 10.1176/appi.ajp.20240709.
    >> Share

  21. KEPINSKA AP, Robakis TK, Humphreys K, Liu X, et al
    Familial Risk of Postpartum Psychosis.
    Am J Psychiatry. 2025 May 19:appiajp20230576. doi: 10.1176/appi.ajp.20230576.
    >> Share

    April 2025
  22. CHENGAPPA KNR, Gannon JM, Joshi YB
    A Call to Psychiatrists: Deprescription of Unnecessary Anticholinergic Medications in Schizophrenia Must Start Now.
    Am J Psychiatry. 2025;182:319-321.
    >> Share

  23. PERLIS RH
    Targeting Schizophrenia.
    Am J Psychiatry. 2025;182:329-331.
    >> Share

  24. ORHAN F, Malwade S, Khanlarkhani N, Gkogka A, et al
    Kynurenic Acid and Promotion of Activity-Dependent Synapse Elimination in Schizophrenia.
    Am J Psychiatry. 2025;182:389-400.
    >> Share

  25. ZHOU L, Sommer IEC, Yang P, Sikirin L, et al
    What Do Four Decades of Research Tell Us About the Association Between Childhood Adversity and Psychosis: An Updated and Extended Multi-Level Meta-Analysis.
    Am J Psychiatry. 2025;182:360-372.
    >> Share

  26. KALIN NH
    Psychotic Disorders and Schizophrenia: Treatment, Risk, Brain Alterations, and Mechanisms.
    Am J Psychiatry. 2025;182:313-315.
    >> Share

  27. NEUFELD NH, Blumberger DM
    An Update on the Use of Neuromodulation Strategies in the Treatment of Schizophrenia.
    Am J Psychiatry. 2025;182:332-340.
    >> Share

    March 2025
  28. CORLETT PR, Fraser KM
    20 Years of Aberrant Salience in Psychosis: What Have We Learned?
    Am J Psychiatry. 2025 Mar 26:appiajp20240556. doi: 10.1176/appi.ajp.20240556.
    >> Share

  29. KALIN NH
    New Developments in the Treatment of Depression, OCD, and Schizophrenia.
    Am J Psychiatry. 2025;182:223-226.
    >> Share

  30. JAVITT DC
    Xanomeline-Trospium Treatment of Cognitive Impairments of Schizophrenia: Hope for Some, or Hope for All?
    Am J Psychiatry. 2025;182:237-239.
    >> Share

    February 2025
  31. OMLOR W, Rabe F, Fuchs S, Surbeck W, et al
    Estimating Multimodal Structural Brain Variability in Schizophrenia Spectrum Disorders: A Worldwide ENIGMA Study.
    Am J Psychiatry. 2025 Feb 26:appiajp20230806. doi: 10.1176/appi.ajp.20230806.
    >> Share

  32. MANCINI V, Latreche C, Fanshawe JB, Varvari I, et al
    Anticholinergic Burden and Cognitive Function in Psychosis: A Systematic Review and Meta-Analysis.
    Am J Psychiatry. 2025 Feb 26:appiajp20240260. doi: 10.1176/appi.ajp.20240260.
    >> Share

  33. TIIHONEN J, Tanskanen A, Solmi M, Rubio JM, et al
    Continuous Dopamine D(2) Receptor Blockade and Long-Term Outcome in First-Episode Schizophrenia.
    Am J Psychiatry. 2025 Feb 19:0. doi: 10.1176/appi.ajp.20240321.
    >> Share

    December 2024
  34. HORAN WP, Sauder C, Harvey PD, Ramsay IS, et al
    The Impact of Xanomeline and Trospium Chloride on Cognitive Impairment in Acute Schizophrenia: Replication in Pooled Data From Two Phase 3 Trials.
    Am J Psychiatry. 2024 Dec 11. doi: 10.1176/appi.ajp.20240076.
    >> Share

    October 2024
  35. GALLUCCI J, Yu JC, Oliver LD, Nakua H, et al
    Neural Circuitry and Therapeutic Targeting of Depressive Symptoms in Schizophrenia Spectrum Disorders.
    Am J Psychiatry. 2024;181:910-919.
    >> Share

  36. REILLY TJ, McCutcheon RA
    Menopausal Hormone Therapy for Women With Schizophrenia: What's Stopping Us?
    Am J Psychiatry. 2024;181:854-855.
    >> Share

  37. KRAMER EN, Velicu V
    Aripiprazole Augmentation as a Treatment for Clozapine-Induced Weight Gain.
    Am J Psychiatry. 2024;181:935-936.
    >> Share

  38. CHENGAPPA KNR, Cotes RO
    Clozapine's High Incidence of Ileus and Pneumonia Demand Better Clinical Strategies-How Do We Get There?
    Am J Psychiatry. 2024;181:851-853.
    >> Share

  39. MCINTYRE RS, Kwan ATH, Rosenblat JD, Teopiz KM, et al
    Aripiprazole Augmentation as a Treatment for Clozapine-Induced Weight Gain: Response to Kramer and Velicu.
    Am J Psychiatry. 2024;181:936-937.
    >> Share

  40. HWANG M, Brady R
    Neural Circuitry and Therapeutic Targeting of Depressive Symptoms in Schizophrenia Spectrum Disorders.
    Am J Psychiatry. 2024;181:858-860.
    >> Share

  41. ARNSTEN AFT, Datta D
    Characterizing the Most Vulnerable Prefrontal Cortical Neurons in Schizophrenia.
    Am J Psychiatry. 2024;181:861-864.
    >> Share

  42. TAMMINGA CA
    Psychosis Risk With Prescription Amphetamine.
    Am J Psychiatry. 2024;181:856-857.
    >> Share

  43. KALIN NH
    Schizophrenia Spectrum Disorders and Psychosis.
    Am J Psychiatry. 2024;181:847-850.
    >> Share

  44. LEUCHT S, Priller J, Davis JM
    Antipsychotic Drugs: A Concise Review of History, Classification, Indications, Mechanism, Efficacy, Side Effects, Dosing, and Clinical Application.
    Am J Psychiatry. 2024;181:865-878.
    >> Share

  45. ARION D, Enwright JF 3rd, Gonzalez-Burgos G, Lewis DA, et al
    Cell Type-Specific Profiles and Developmental Trajectories of Transcriptomes in Primate Prefrontal Layer 3 Pyramidal Neurons: Implications for Schizophrenia.
    Am J Psychiatry. 2024;181:920-934.
    >> Share

    September 2024
  46. PARTANEN JJ, Happola P, Kampe A, Ahola-Olli A, et al
    High Burden of Ileus and Pneumonia in Clozapine-Treated Individuals With Schizophrenia: A Finnish 25-Year Follow-Up Register Study.
    Am J Psychiatry. 2024 Sep 12:appiajp20230744. doi: 10.1176/appi.ajp.20230744.
    >> Share

  47. MORAN LV, Skinner JP, Shinn AK, Nielsen K, et al
    Risk of Incident Psychosis and Mania With Prescription Amphetamines.
    Am J Psychiatry. 2024 Sep 12:appiajp20230329. doi: 10.1176/appi.ajp.20230329.
    >> Share

  48. BRAND BA, Sommer IE, Gangadin SS, Tanskanen A, et al
    Real-World Effectiveness of Menopausal Hormone Therapy in Preventing Relapse in Women With Schizophrenia or Schizoaffective Disorder.
    Am J Psychiatry. 2024 Sep 12:appiajp20230850. doi: 10.1176/appi.ajp.20230850.
    >> Share

    July 2024
  49. JONSSON L, Horbeck E, Primerano A, Song J, et al
    Association of Occupational Dysfunction and Hospital Admissions With Different Polygenic Profiles in Bipolar Disorder.
    Am J Psychiatry. 2024;181:620-629.
    >> Share

    June 2024
  50. KURTZ MM
    Cognitive Remediation in Schizophrenia Spectrum Illness: Evidence for Treatment Persistence.
    Am J Psychiatry. 2024;181:471-473.
    >> Share

  51. VANO LJ, Veronese M, McCutcheon RA, Howes OD, et al
    Neuromelanin-Sensitive MRI: A Biomarker for Treatment-Resistant Schizophrenia?
    Am J Psychiatry. 2024;181:468-470.
    >> Share

  52. BRENNAND KJ
    Aligning Stem Cell Models and Postmortem Studies to Query Striatal Neurodevelopment in Schizophrenia.
    Am J Psychiatry. 2024;181:465-467.
    >> Share

  53. BIRNBAUM R, Weinberger DR
    The Genesis of Schizophrenia: An Origin Story.
    Am J Psychiatry. 2024;181:482-492.
    >> Share

  54. KALIN NH
    Advances in Understanding Schizophrenia, ADHD, and ASD.
    Am J Psychiatry. 2024;181:461-464.
    >> Share

  55. TRAMAZZO S, Lian W, Ajnakina O, Carlson G, et al
    Long-Term Course of Remission and Recovery in Psychotic Disorders.
    Am J Psychiatry. 2024;181:532-540.
    >> Share

    May 2024
  56. KANG J, Castro VM, Ripperger M, Venkatesh S, et al
    Genome-Wide Association Study of Treatment-Resistant Depression: Shared Biology With Metabolic Traits.
    Am J Psychiatry. 2024 May 15:appiajp20230247. doi: 10.1176/appi.ajp.20230247.
    >> Share

    April 2024
  57. LIGHT GA, Swerdlow NR
    Predicting Conversion to Psychosis: What Lies Beyond the Biomarkers?
    Am J Psychiatry. 2024;181:272-274.
    >> Share

    March 2024
  58. VAN DER PLUIJM M, Wengler K, Reijers PN, Cassidy CM, et al
    Neuromelanin-Sensitive MRI as Candidate Marker for Treatment Resistance in First-Episode Schizophrenia.
    Am J Psychiatry. 2024 Mar 13:appiajp20220780. doi: 10.1176/appi.ajp.20220780.
    >> Share

  59. VITA A, Barlati S, Ceraso A, Nibbio G, et al
    Durability of Effects of Cognitive Remediation on Cognition and Psychosocial Functioning in Schizophrenia: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.
    Am J Psychiatry. 2024 Mar 13:appiajp20230396. doi: 10.1176/appi.ajp.20230396.
    >> Share

    February 2024
  60. HOU Y, Xia H, He T, Zhang B, et al
    N2 Responses in Youths With Psychosis Risk Syndrome and Their Association With Clinical Outcomes: A Cohort Follow-Up Study Based on the Three-Stimulus Visual Oddball Paradigm.
    Am J Psychiatry. 2024 Feb 29:appiajp20221013. doi: 10.1176/appi.ajp.20221013.
    >> Share

  61. ROGNLI EB, Hoye A, Bramness JG
    Methamphetamine-Induced Psychosis and Schizophrenia: A Call for Special Attention: Response to Zhu et al.
    Am J Psychiatry. 2024;181:168-169.
    >> Share

  62. ZHU L, Ni T, Guan F
    Methamphetamine-Induced Psychosis and Schizophrenia: A Call for Special Attention.
    Am J Psychiatry. 2024;181:168.
    >> Share

    November 2023
  63. SAWADA T, Barbosa AR, Araujo B, McCord AE, et al
    Recapitulation of Perturbed Striatal Gene Expression Dynamics of Donor's Brains With Ventral Forebrain Organoids Derived From the Same Individuals With Schizophrenia.
    Am J Psychiatry. 2023 Nov 2:appiajp20220723. doi: 10.1176/appi.ajp.20220723.
    >> Share

  64. KALIN NH
    New Insights Into Psychotic Disorders.
    Am J Psychiatry. 2023;180:779-781.
    >> Share

  65. VAN DER VEN E, Susser E
    Structural Racism and Risk of Schizophrenia.
    Am J Psychiatry. 2023;180:782-784.
    >> Share

  66. CANNON TD
    Predicting Conversion to Psychosis Using Machine Learning: Are We There Yet?
    Am J Psychiatry. 2023;180:789-791.
    >> Share

  67. GOFF DC, Roffman J, Holt DJ
    Another Step Toward the Prediction of Antipsychotic Treatment Response Using Functional Connectivity.
    Am J Psychiatry. 2023;180:787-788.
    >> Share

  68. FORSYTH JK, Bearden CE
    Rethinking the First Episode of Schizophrenia: Identifying Convergent Mechanisms During Development and Moving Toward Prediction.
    Am J Psychiatry. 2023;180:792-804.
    >> Share

  69. STRAWBRIDGE RJ, Graham N
    Dissecting the Genetic Relationship Between Schizophrenia and Cardiovascular Disease.
    Am J Psychiatry. 2023;180:785-786.
    >> Share

  70. JOSHI Y, Swerdlow N, Light G
    Points that Need Attention in Early Auditory Information Processing Research in Schizophrenia: Response to Lin and Hsieh.
    Am J Psychiatry. 2023;180:841-842.
    >> Share

    October 2023
  71. SMUCNY J, Davidson I, Carter CS
    Are We There Yet? Predicting Conversion to Psychosis Using Machine Learning.
    Am J Psychiatry. 2023 Oct 4:appiajp20220973. doi: 10.1176/appi.ajp.20220973.
    >> Share

    September 2023
  72. RODEVAND L, Rahman Z, Hindley GFL, Smeland OB, et al
    Characterizing the Shared Genetic Underpinnings of Schizophrenia and Cardiovascular Disease Risk Factors.
    Am J Psychiatry. 2023 Sep 27:appiajp20220660. doi: 10.1176/appi.ajp.20220660.
    >> Share

  73. KUMAR K, Modenato C, Moreau C, Ching CRK, et al
    Subcortical Brain Alterations in Carriers of Genomic Copy Number Variants.
    Am J Psychiatry. 2023;180:685-698.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016